Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin (DAB389EGF)

Cancer Journal from Scientific American

Volumn 2, Issue 3, 1996, Pages 175-180

  Osborne, C Kent ^a   Coronado Heinsohn, Ester ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Breast cancer; EGF receptor; Treatment

Indexed keywords

DAB389EGF PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN;

ARTICLE; BREAST TUMOR; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PROTEIN SYNTHESIS; TIME; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; PROTEIN BIOSYNTHESIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; TIME FACTORS;

EID: 0344783792     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Osborne CK, Hamilton B, Titus G, Livingston RB. Epidermal growth factor stimulation of human breast cancer cells in culture. Cancer Res 1980;40:2361-2366.
2. Osborne CK, Hamilton B, Nover M. Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab 1982;55:86-93.
3. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 1994;29:41-49.
4. Nicholson RJ, McClelland RA, Gee JMW et al. Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Res Treat 1994;29:117-125.
5. Ennis BW, Lippman ME, Dickson RB. The EGF receptor system as a target for antitumor therapy. Cancer Invest 1991;9:553-562.
6. Pai LH, Gallo MG, FitzGerald DJ, Pastan I. Antitumor activity of a transforming growth factor a-Pseudomonas exotoxin fusion protein (TGF-a-PE40). Cancer Res 1991;51:2808-2812.
7. Heimbrook DC, Stirdivant SM, Ahern JD et al. Transforming growth factor α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc Natl Acad Sci USA 1990;87:4697-4701.
8. Siegall CB, Xu Y-H, Chaudhary VK, Adhya S, FitzGerald D, Pastan I. Cytotoxin activities of a fusion protein comprised of TGF-α and Pseudomonas exotoxin. FASEB J 1989;3:2647-2652.
9. Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Cancer Res 1989;49:3482-3488.
10. Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor α-Pseudomonas exotoxin 40 fusion protein. Cancer Res 1994;54:4703-4709.
11. Phillips PCV, Levow C, Catterall M, Colvin OM, Pastan I, Brem H. Transforming growth factor α-Pseudomonas exotoxin fusion protein (TGF-α-PE38) treatment of subcutaneous and intracranial human glioma amd medulloblastoma xenografts in athymic mice. Cancer Res 1994;54:1008-1015.
12. 589EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J Biol Chem 1991;266:21118-21124.
13. Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer lines. Mol Endocrinol 1987;1:216-223.
14. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 1988;48:3898-3904.
15. Pfeiffer A, Rothbauer E, Wiebecke B, Pratschke E, Kramling H-J, Mann K. Increased epidermal growth factor receptors in gastric carcinoma. Gastroenterology 1990;98:961-967.
16. Libermann TA, Nusbaum HR, Razon N et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 1985;313:144-147.
17. Rajkumar T, Gullick WJ. The Type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 1994;29:3-9.
18. 589EGF, an epidermal growth factor receptor targeted fusion toxin, administered as an infusion in a rat tumor model [abstract]. Proc Am Acad Cancer Res 1994;35:381.
19. 389EGF in patients with solid malignancies that express EGF receptors [abstract]. Proc Am Soc Clin Oncol 1995;14:480.
20. Gladhaug IP, Christoffersen T. Amiloride inhibits constitutive internalization and increases the surface number of epidermal growth factor receptors in intact rat hepatocytes. J Cell Physiol 1990;143:188-195.
21. Lai WH, Cameron PH, Wada I et al. Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J Cell Biol 1989;109:2741-2749.